252 related articles for article (PubMed ID: 16146652)
1. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
2. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
[TBL] [Abstract][Full Text] [Related]
3. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
4. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
5. Presence of donor-derived thymic epithelial cells in [B6-->MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT).
Takaki T; Hosaka N; Miyake T; Cui W; Nishida T; Inaba M; Ikehara S
J Autoimmun; 2008 Dec; 31(4):408-15. PubMed ID: 19022623
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
7. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
[TBL] [Abstract][Full Text] [Related]
8. A new bone marrow transplantation method for stem cell disorders.
Ikehara S
Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow cells as an origin of immune-mediated hearing loss.
Iwai H; Lee S; Baba S; Tomoda K; Inaba M; Ikehara S; Yamashita T
Acta Otolaryngol; 2004 Jan; 124(1):8-12. PubMed ID: 14977070
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
Trune DR; Kempton JB; Gross ND
Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
Trune DR; Kempton JB; Kessi M
Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
[TBL] [Abstract][Full Text] [Related]
13. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
[TBL] [Abstract][Full Text] [Related]
14. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
[TBL] [Abstract][Full Text] [Related]
15. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
[TBL] [Abstract][Full Text] [Related]
16. New strategies for BMT, organ transplantation, and regeneration therapy.
Ikehara S
Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
[TBL] [Abstract][Full Text] [Related]
17. Transfer of accelerated presbycusis by transplantation of bone marrow cells from senescence-accelerated mice.
Baba S; Iwai H; Inaba M; Kawamoto K; Omae M; Yamashita T; Ikehara S
Brain Res; 2006 Nov; 1120(1):93-9. PubMed ID: 17011530
[TBL] [Abstract][Full Text] [Related]
18. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
[TBL] [Abstract][Full Text] [Related]
19. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.
Trune DR; Kempton JB; Harrison AR; Wobig JL
Hear Res; 2007 Apr; 226(1-2):209-17. PubMed ID: 17098384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]